Founder / CEO in Muenchen, Deutschland

About Spira Labs

Spira Labs is an early-stage TechBio and HealthTech venture builder based in Munich, Germany.
Backed by Picus Capital and Arvantis Group, and supported by leading industry experts, we partner with exceptional founders from the earliest stages to turn ambitious ideas into scalable healthcare and life science companies.

We focus on data- and AI-driven business models across diagnostics, life sciences and healthcare delivery, combining deep domain expertise with hands-on support across the early-stage phases, from product development to go-to-market.

We are looking for an exceptional entrepreneur to take the lead in one of our incubated ventures, building a next-generation diagnostics company at the intersection of metagenomics, data science and precision medicine. The ambition is to combine increasingly accessible sequencing technology with advanced bioinformatics to develop clinically meaningful products while building a proprietary data foundation for future diagnostic applications.

What you will do

As Founder / CEO, you will take the helm of a fast-moving startup, leveraging the declining cost of metagenomic sequencing to build a category-leading, data-driven molecular diagnostics platform.

Your responsibilities include:

• Define and execute the company's vision, strategy and product roadmap

• Drive scientific validation, product development and commercialization

• Build and lead a high-performing team and build out strategic partnerships with labs

• Drive commercial growth, fundraising and investor relations

• Take full ownership of company execution, operations and performance

Your profile

• Strong background in data-driven / digital healthcare, diagnostics or precision medicine

• Experience in healthcare or diagnostic product development and/or commercialization, ideally with exposure to laboratory workflows, clinical validation and/or regulatory requirements (MDR/IVDR)

• Solid scientific and analytical judgment, with the ability to critically assess clinical evidence, technical feasibility and commercial potential

• Strong commercial acumen, ideally with experience in go-to-market, sales, partnerships or early customer traction in healthcare or life sciences

• Entrepreneurial experience in building products, businesses or new initiatives from the ground up, ideally in resource-constrained environments

• Inspiring and credible leader with the ability to attract exceptional talent, build high-performing teams and establish strong industry relationships

• Strong communication skills with the ability to translate complex science into compelling products, business opportunities and investor narratives

• High agency, ownership mindset and evidence-driven decision-making
  

What we offer

• Opportunity to build and lead a company at the intersection of metagenomics, AI and precision medicine, with meaningful founder equity

• Direct access to experienced entrepreneurs, investors, clinicians and scientists across the Spira Labs, Picus Capital and Arvantis Group networks

• Ongoing partnership discussions with three leading diagnostic laboratories in Germany, providing a strong foundation for scientific validation, product development and commercialization

• Hands-on venture-building support, initial funding and access to operational resources and expertise

• High degree of entrepreneurial autonomy, with a lean team, fast decision-making and the freedom to shape the company from day one

• Flexible working arrangements and an attractive office in central Munich